Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected? (Q39392865)

11 September 2017

title

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected? (English)

1 reference

11 September 2017

2

Kundi M

1 reference

11 September 2017

Rendi-Wagner P

1

1 reference

11 September 2017

Zent O

3

1 reference

11 September 2017

Dvorak G

4

1 reference

11 September 2017

Jaehnig P

5

1 reference

11 September 2017

Holzmann H

6

1 reference

11 September 2017

Mikolasek A

7

1 reference

11 September 2017

Kollaritsch H

8

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

11 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

11 September 2017

volume

22

1 reference

11 September 2017

issue

21-22

1 reference

11 September 2017

page(s)

2743-2749

1 reference

11 September 2017

cites work

History of TBE vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Laboratory findings in tick-borne encephalitis--correlation with clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Diagnosis of tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Genetic prediction of nonresponse to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Costimulatory mechanisms in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Primary and secondary alterations of immune reactivity in the elderly: impact of dietary factors and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

In vitro senescence models for human T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

Persistence of vaccine-induced antibody to hepatitis A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

TBE vaccination and the Austrian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.041

10.1016/J.VACCINE.2004.01.041

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference